李争鸣周秀萍林梅李秀萍.口服卡介菌诱导免疫耐受的CD4+CD25+调节性T 细胞机制研究[J].,2012,12(12):2278-2281 |
口服卡介菌诱导免疫耐受的CD4+CD25+调节性T 细胞机制研究 |
Studies on CD4+CD25+ T Regulatory Cells in Immune ToleranceInduced by Oral BCG* |
|
DOI: |
中文关键词: 卡介菌 免疫耐受 实验性变态反应性脑脊髓炎 CD4+CD25+T 淋巴细胞 |
英文关键词: BCG Immune tolerance EAE CD4+CD25+T regulatory cell |
基金项目:湖南省教育厅课题资助项目(06C069) |
|
摘要点击次数: 905 |
全文下载次数: 0 |
中文摘要: |
目的:研究口服卡介菌诱导免疫耐受对CD4+CD25+ 调节性T 细胞的影响。方法:采用口服MPB 制备EAE 大鼠模型,随机分
为BCG 组(0.5mg/kg)和EAE 模型组(PBS),每组各15 只,连续经口灌服给药14d,同时选取15 只健康大鼠作为对照组。分别于
免疫后15d、27d 流式细胞术检测外周血、胸腺及脾脏中CD4+CD25+T 淋巴细胞百分率,ELISA 检测血清IL-6、TGF-β、IgE、IgG 含
量。结果:与EAE 模型组相比,免疫后BCG 组大鼠外周血、胸腺及脾脏中CD4+CD25+T 淋巴细胞百分率增加,血清IL-6、TGF-β
含量上升,血清IgE、IgG 抗体水平下降。结论:口服BCG 通过上调淋巴器官中CD4+CD25+T 淋巴细胞比例,抑制效应性T 细胞活
性,发挥免疫耐受作用。 |
英文摘要: |
Objective: To investigate the influence of oral BCG on CD4+ CD25+ T regulatory cells in inducing immune tolerance.
Methods: The EAE rats, induced by immunization with oral MBP, were randomly divided into BCG group (0.5mg/kg) and EAE group
(PBS), with 15 rats per group, and 15 normal rats were used as control group. On 15d and 27d after treatment, CD4+ CD25+ T regulatory
cells from peripheral blood, thymus and spleen were respectively determined by flow cytometry, and levels of serum IL-6, TGF-β, IgE
and IgG were measured by ELISA. Results: Compared with EAE group, CD4+ CD25+ T regulatory cells from peripheral blood, thymus
and spleen, and levels of IL-6 and TGF-β increased in BCG group after treatment, but serum IgE and IgG levels decreased. Conclusion:
Oral BCG could induce immune tolerance by up-regulating the percentage of CD4+ CD25+ T regulatory cells, inhibiting effector T cell
function. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |